Holen Sie sich die Stockscreener-App
0.571
4.83%
-0.029
Traws Pharma Inc Aktie (TRAW) Neueste Nachrichten
Ikarian Capital (TRAW) reports 1.56M-share, 9.5% beneficial stake in Traws Pharma - Stock Titan
Traws Pharma Flags Cash Runway Risk Into Q1 2027 Amid FDA Clinical Hold - Minichart
Traws Pharma Reports Q2 Results, Influenza Program Advances - TipRanks
Traws Pharma Q2 Results: EPS beats estimate, losses widen 45% YoY - scanx.trade
Traws Pharma Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Traws Pharma Reports Q2 2026 Financial Results and Provides Business Highlights - The Manila Times
Traws Pharma Q2 revenue falls to zero on licensing termination; net loss widens - TradingView
Traws Pharma Reports Q2 2026 Net Loss of $3.0 Million - Quiver Quantitative
Traws Pharma Expects Q3 Resubmission for Flu Antiviral - Stock Titan
Traws Pharma (TRAW) investor Squadron reports 0% beneficial ownership in 13G/A - Stock Titan
Sirenia Capital (TRAW) discloses warrant-based stake capped at 9.9% ownership - Stock Titan
Traws Pharma Inc (NASDAQ: TRAW) Share Price, TRAW Stock News, TRAW Share Price & Updates - Kalkine
Adage Capital reports 4.79% Traws Pharma (TRAW) stake totaling 730,000 shares - Stock Titan
Why Did TRAW Stock Slump 28% After Hours? - Stocktwits
Traws Pharma Inc expected to post a loss of 34 cents a shareEarnings Preview - TradingView
Traws Pharma Inc (TRAW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Traws Pharma Inc (TRAW) Stock News Today - TradingKey
TRAW Q2'26 Earnings: EPS estimate is (0.34) USD - TradingView
TRAW Moves TRX-100 Through Early Human Testing: What Investors Should Watch - TipRanks
Traws Pharma, Inc. Revenue Breakdown – NASDAQ:TRAW - TradingView
Traws Pharma Q1 2026 Earnings: Narrower-Than-Expected Loss Lifts Investor SentimentROIC Trend Report - dars.gov.et
Traws Pharma Receives Nasdaq Minimum Bid Price Notice - TipRanks
Traws Pharma Received Notice of Noncompliance - TradingView
Traws Pharma Inc (TRAW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
TRAW Q2'26 Earnings: revenue estimate is 0 USD - TradingView
Traws Pharma Inc (TRAW) Balance Sheet - TradingKey
TRAW|Traws Pharma Inc|Price:0.520|Chg%:+0.032 - TradingKey
Traws Pharma Inc (TRAW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Traws Pharma Inc (TRAW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TRAW|Traws Pharma Inc|Price:0.544|Chg%:+0.004 - TradingKey
TRAW|Traws Pharma Inc|Price:0.488| - TradingKey
Traws Pharma, Inc. Revenue Breakdown – LS:A40PJ7 - TradingView
Traws Pharma Inc (TRAW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Traws Pharma Inc (TRAW) Income Statement - TradingKey
Traws Pharma Inc (TRAW) Cash Flow - TradingKey
Traws Pharma Inc (TRAW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Traws Pharma (TRAW) Slides 10.6% as Selling Pressure IntensifiesTurnaround Stocks - dars.gov.et
Traws Pharma (TRAW) Registration filing Summary - Quartr
Traws Pharma Inc. (TRAW) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Positive Investor SentimentGeographic Revenue Trends - dars.gov.et
Form 4 Traws Pharma Inc For: 16 July By Investing.com - Investing.com Nigeria
Traws Pharma (TRAW) grants 97,000 stock options to science chief - Stock Titan
Traws Pharma (TRAW) awards 14,150 stock options to director Cautreels - Stock Titan
Form 4 Traws Pharma Inc For: 15 July By Investing.com - Investing.com Nigeria
Traws Pharma (TRAW) awards COO 93,000 stock options at $0.68 strike - Stock Titan
Traws Pharma (TRAW) awards 14,150 stock options to director Jack E. Stover - Stock Titan
Form 4 Traws Pharma Inc For: 14 July By Investing.com - Investing.com India
Traws Pharma (TRAW) awards CMO 84,000 stock options at $0.68 - Stock Titan
Traws Pharma (TRAW) awards 14,150 stock options to board director - Stock Titan
Traws Pharma (TRAW) grants CFO Parker Nolan 90,000 stock options - Stock Titan
Traws Pharma (TRAW) awards 14,150 stock options to company director - Stock Titan
Traws Pharma stock falls as UK regulator delays key flu study - MSN
Traws Pharma Announces New At-The-Market Offering Program - The Globe and Mail
Traws Pharma, Inc. Files Form 8-K on Nasdaq Under Symbol TRAW – Company Details and Legal Opinion Included - Minichart
Form 424B5 Traws Pharma Inc For: 10 July - Investing.com UK
Form 424B5 Traws Pharma Inc For: 10 July By Investing.com - Investing.com South Africa
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):